Trial Details

COMPLETED
Basic Information
Clinical ID c3626
Identifier NCT01768858
Trial Title Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Crohn´s Disease|Ulcerative Colitis|Plaque Psoriasis
Interventions DRUG: Adalimumab
Participant Information
Sponsor AbbVie
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2013-02-05
Primary Completion Date 2017-08-13
Completion Date 2017-08-13